| Viatris Pharma GmbH - Sunitinib Viatris 12.5 mg, Hartkapseln | | 68094 | | 01 | | Sunitinib Viatris 12.5 mg | | Hartkapseln | | L01EX01 | | Sunitinib | | 29.03.2021 | | |
| | Composition | | sunitinibum 12.5 mg, cellulosum microcristallinum, mannitolum, carmellosum natricum conexum corresp. natrium, povidonum, magnesii stearas, Kapselhülle: E 172 (rubrum), E 171, gelatina, Drucktinte: lacca, E 171, propylenglycolum, pro capsula. | | Packungsbestandteile | | Capsules | | | | | Principe actif | Concentr. |
|---|
| Sunitinib | 12.5 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Sunitinib | 12.5 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| (Rubrum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | Kapselhülle | | Gelatina | | | | Lacca | | Drucktinte | | Magnesii Stearas | | | | Mannitol | | | | Povidone | | | | Pro Capsula | | | | Propylenglycol | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 004 | 28 | 800.81 | 887.35 | A | LS | Non |
|
|
